Laser may offer new hope for women with chronic vulvar condition

NCT ID NCT07240519

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a fractional CO2 laser can reduce inflammation and symptoms like itching and pain in vulvar lichen sclerosus, a chronic skin condition. Forty women who have not been treated before will receive either standard clobetasol ointment or three laser sessions. Researchers will compare skin biopsies and symptom scores to see if laser is a good alternative to long-term steroid use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VULVAR LICHEN SCLEROSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute of Gynecology of the Federal University of Rio de Janeiro

    RECRUITING

    Rio de Janeiro, Rio de Janeiro, 20211 340, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.